CDC42 and breast carcinoma: Reymond and colleagues identified Cdc42 as a critical regulator of breast cancer cell intravasation, as RNAi targeting of Cdc42 significantly inhibited the ability of MDA-MB-231 cells to migrate and invade through a layer of endothelial cells [103].